Ju Bo Liu

Chief Executive Officer at Novotek Pharmaceuticals Ltd.

Ju Bo Liu

Ju Bo Liu

Chief Executive Officer at Novotek Pharmaceuticals Ltd.

Overview
Career Highlights

Novotek Medicinal Technology Development Co., Ltd.
Novotek Pharmaceuticals Ltd.

RelSci Relationships

49

Number of Boards

2

Birthday

1973

Age

45

Relationships
RelSci Relationships are individuals Ju Bo Liu likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer & Member-Management Board at Bioton SA

Relationship likelihood: Strong

Chairman & Chief Executive Officer at SciGen Ltd.

Relationship likelihood: Strong

Non-Independent Non-Executive Director at SciGen Ltd.

Relationship likelihood: Strong

Former Director-Business Development at PT Capsugel Indonesia

Relationship likelihood: Strong

Senior Vice President & Company Secretary at SciGen Ltd.

Relationship likelihood: Strong

Co-Founder at Goldmark Plastic Compounds, Inc.

Relationship likelihood: Strong

Director-Foreign Markets at Bioton SA

Relationship likelihood: Strong

Former Director at SciGen Ltd.

Relationship likelihood: Strong

Former Investment Manager at Phoenix Pharma Polska SP zoo

Relationship likelihood: Strong

Former President at Prokom Software SA

Relationship likelihood: Strong

Paths to Ju Bo Liu
Potential Connections via
Relationship Science
You
Ju Bo Liu
Chief Executive Officer at Novotek Pharmaceuticals Ltd.
Education
Class of 2006

Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.

Career History
Chief Executive Officer
2009 - Current
Chief Executive Officer
Current

NovoTek Pharmaceuticals Ltd., a subsidiary of Yifan Pharmaceutical Co., Ltd., is a company headquartered in Hong Kong. The firm manufactures pharmaceutical products. It was founded by Ju Bo Liu, who is currently the CEO of the company.

Director-Marketing & Regulatory Affairs
1997 - 2001
Boards & Committees
Non-Executive Director
2017 - Current

SciGen Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Bangladesh, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The Bangladesh segment engages in the sale of insulin bulk active ingredients. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.

Chairman, Supervisory Board
Current

BIOTON SA engages in the manufacture and production of medicines and pharmaceutical substances. It offers oral hypoglycemic drug, foot cream and human insulin. It operates through the following segment: BIOTON S.A. and BIOTON MARKETING AGENCY Sp. z o.o.; SciGen Ltd Group; BioPartners Holding AG Group; MJ BioPharm Prv Ltd; Fisiopharma S.r.l. and Pharmatex S.r.l.; Copernicus Sp. z o.o.; BIOLEK Sp. z o.o. Group; BIOTON International GmbH (former name Actavis BIOTON GmbH), and MJ BIOTON Life Sciences Ltd. The company was founded on August 24, 1989 and is headquartered in Warsaw, Poland.